Publications by authors named "Mark Flasar"

Claim this Profile
R
Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
Seema A Patil, Mark H Flasar, Jay Lin, Melissa Lingohr-Smith, Martha Skup

Dig Dis Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia.
Kamini Shah, Bryan F Curtin, Christopher Chu, Daniel Hwang, Mark H Flasar

World J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
Mark H Flasar, Jingdong Chao, A Burak Ozbay, Martha Skup, Mei Lu

Inflamm Bowel Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs".
Soundarya Vaithianathan, Sam H Haidar, Xinyuan Zhang, Wenlei Jiang, Christopher Avon, Mark H Flasar

J Pharm Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir.
Soundarya Vaithianathan, Sam H Haidar, Xinyuan Zhang, Wenlei Jiang, Christopher Avon, Mark H Flasar

J Pharm Sci· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper.
Stefan D Holubar, Jennifer Holder-Murray, Mark Flasar, Mark Lazarev

Inflamm Bowel Dis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the need for comparative effectiveness studies in IBD?
Mark H Flasar, Raymond K Cross

Expert Rev Gastroenterol Hepatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in disease activity and quality of life in patients with Crohn's disease.
Leyla J Ghazi, Alison D Lydecker, Seema A Patil, Ankur Rustgi, Raymond K Cross, Mark H Flasar

Dig Dis Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Health Survey of Gastroenterologist Prescribing Practices of Adalimumab for Treatment of Crohn's Disease: Final Results.
Samantha Zullow, Mark H Flasar, Deborah Greenberg, J Kathleen Tracy, Ankur Rustgi

Gastroenterol Hepatol (N Y)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiating disparity in IBD.
Mark Flasar, Seema Patil

Dig Dis Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Kotze et al.
Mark Flasar, Ali Syed, Raymond K Cross

Am J Gastroenterol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile-associated disease: adherence with current guidelines at a tertiary medical center.
Bryan F Curtin, Yousef Zarbalian, Mark H Flasar, Erik von Rosenvinge

World J Gastroenterol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step up versus early biologic therapy for Crohn's disease in clinical practice.
Leyla J Ghazi, Seema A Patil, Ankur Rustgi, Mark H Flasar, Sanam Razeghi

Inflamm Bowel Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Ali Syed, Raymond K Cross, Mark H Flasar

Am J Gastroenterol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TNF therapy is associated with decreased imaging and radiation exposure in patients with Crohn's disease.
Seema A Patil, Ankur Rustgi, Sandra M Quezada, Mark H Flasar, Fauzia Vandermeer

Inflamm Bowel Dis· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic ferromagnetic object retrieval by use of a simple magnet (with video).
Florence M Aslinia, Mark H Flasar

Gastrointest Endosc· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future role of serogenomics in ulcerative colitis.
Mark H Flasar, Raymond K Cross, David B Doman

Gastroenterol Hepatol (N Y)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast does not affect cholangioscope image quality.
Jeffrey Laczek, Mark Flasar, Eric Goldberg, Peter Darwin

Gut Liver· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study.
Roxana Samimi, Mark H Flasar, Stephen Kavic, Kathleen Tracy, Raymond K Cross

Inflamm Bowel Dis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dialysis reduces portal pressure in patients with chronic hepatitis C.
Sandeep Khurana, Thomas Simcox, William Twaddell, Cinthia Drachenberg, Mark Flasar

Artif Organs· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study.
Mark H Flasar, Sandra Quezada, Priti Bijpuria, Raymond K Cross

Dig Dis Sci· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.
Mark H Flasar, Tamara Johnson, Mary-Claire Roghmann, Raymond K Cross

Inflamm Bowel Dis· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute abdominal pain.
Mark H Flasar, Raymond Cross, Eric Goldberg

Prim Care· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute abdominal pain.
Mark H Flasar, Eric Goldberg

Med Clin North Am· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis